SFM
VBIV

Sphera Funds Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Sphera Funds Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-22,209
Closed -$2.33M – 131
2018
Q1 		$2.33M Sell
22,209
-4,458
-17% -$532K 0.35% 73
2017
Q4 		$3.42M Buy
+26,667
New +$3.28M 0.4% 61

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return

Sphera Funds Management's VBIV Position: Q2 2018 in Review

Sphera Funds Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2018, closing a stake of 22,209 shares — an estimated $2.33M sold.

Sphera Funds Management first reported a position in VBIV in Q4 2017 and held it in 2 quarters. The position peaked at $3.42M in Q4 2017. 48 funds tracked by Wall St. Rank hold VBIV as of Q2 2018.

  • Sphera Funds Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2018 after selling out during the quarter.
  • Sphera Funds Management sold 22,209 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2018, an estimated $2.33M.
  • Sphera Funds Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 2 quarters.
  • Sphera Funds Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $3.42M in Q4 2017.
  • 48 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2018.

Based on Sphera Funds Management's 13F filing for Q2 2018, filed 13 Aug 2018.